Sigma-Aldrich and Oxford BioMedica win key ruling in open
biosystems patent Infringement dispute.
Sigma-Aldrich (St. Louis, MO), a life science company dedicated to
providing state-of-the-art chemical and biotechnology products to the
world's researchers, and Oxford BioMedica (Oxford, England), . . .
Quest Diagnostics licenses technology underlying SensiTrop HIV
co-receptor tropism test from pathway diagnostics -First national
Quest Diagnostics Incorporated (Madison, NJ), the nation's
leading provider of diagnostic testing, information and services,
announced that it has entered into a non- exclusive license . . .
New United States patent granted for Nventa's Coval HPV
fusions to treat patients with HPV-related diseases.
Nventa Biopharmaceuticals Corporation (San Diego, CA) announced
that the United States Patent and Trademark Office has issued Patent
Number 7,262,014 to Nventa covering compositions and methods . . .
WellGen proceeds to build pipeline of patented nutraceuticals and
advance product development programs.
WellGen, Inc. (North Brunswick, NJ), a biotechnology company using
nutrigenomics to discover and develop food ingredients for wellness
products, announced the completion of its Series C financing . . .
Xenomics announces license with Asuragen for NPM1 leukemia
diagnostics.
Xenomics, Inc. (New York, NY) has granted Asuragen, Inc.
co-exclusive worldwide rights to incorporate NPM1 technology into
Asuragen's molecular diagnostic products. Under the terms of . . .
NPS Pharmaceuticals obtains United States patent.
NPS Pharmaceuticals, Inc. (Salt Lake City, UT) has patented a human
metabotropic glutamate receptor (mGluR) protein is identified,
sequenced, and cloned. The receptor may be used to screen for . . .
United States Department of Energy obtains United States
patent.
United States Department of Energy (Washington, DC) has patented
cellulose synthase ("CS"), a key enzyme in the biosynthesis of
cellulose in plants is inhibited by herbicides . . .
University of California obtains United States patent.(Brief
article)
University of California (Oakland, CA) has patented a specific
clinical protocol for use toward therapy of defective, diseased and
damaged cholinergic neurons in the mammalian brain, of . . .
E. I. du Pont de Nemours obtains United States patent.(E. I. du
Pont de Nemours and Company)(Brief article)
E. I. du Pont de Nemours and Company (Wilmington, DE) has patented
the preparation and use of nucleic acid fragments encoding plant fatty
acid modifying enzymes associated with conjugated double . . .
Purac Biochem obtains United States patent.
Purac Biochem B.V. (Gorinchem, Netherlands) has patented processes
to separate the biomass from the lactic acid-containing fermentation
product by means of flocculation. The process involves . . .
National Research Council obtains United States patent.(Brief
article)
National Research Council of Canada (Ottawa, Canada) has patented
fusion polypeptides that include a glycosyltransferase catalytic domain
and a catalytic domain from an accessory enzyme that is . . .
Cayla obtains United States patent.
Cayla (Toulouse Cedex, France) has patented a new series of
bacterial plasmid vectors which are fully devoid of CpG and which can
express synthetic genes which do not contain CpG in the . . .
Bayer obtains United States patent.
Bayer Pharmaceuticals Corporation (Berkeley, CA) has patented a
method for increased production of a secreted, recombinant protein
product through the introduction of molecular chaperones in a . . .
Purdue obtains United States patent.(Purdue Research
Foundation)(Brief article)
Purdue Research Foundation (W. Lafayette, IN) has patented
pyridines, pharmaceutical compositions comprising such pyridines, and
the use of such compositions in treating injured mammalian nerve . . .
Pharma Pacific obtains United States patent.
Pharma Pacific Pty. Ltd. (Victoria, Australia) has patented a
method of identification of a gene upregulated by interferon-.alpha.
administration corresponding to the cDNA sequence set forth in . . .
Roche obtains United States patent.
Roche Diagnostics Operations, Inc. (Indianapolis, IN) has patented
cloning and expression of foreign protein or polypeptides in bacteria,
such as Escherichia coli. In particular, this invention . . .
Genentech obtains United States patent.
Genentech, Inc. (South San Francisco, CA) has patented new tumor
necrosis factor receptor associated factors, designated TRAF. The new
factors are capable of specific association with the . . .
Bayer Bioscience obtains United States patent.(Brief
article)
Bayer Bioscience N.V. (Ghent, Belgium) has patented insecticidal
compounds derived from Bacillus thuringiensis strains. Nucleotide
sequences encoding a Cry2Ae protein and truncated fragments . . .
MDS obtains United States patent.(Brief article)
MDS (Canada), Inc. (Ontario, Canada) has patented attenuated,
tumor-targeting bacterium comprising a heterologous nucleotide sequence
encoding a protein permitting the accumulation of a . . .
ZymoGenetics establishes global collaboration with Bayer for
development and commercialization of recombinant human thrombin.
ZymoGenetics, Inc.(Seattle, WA) entered into multi-year, domestic
and global license and collaboration agreements with Bayer HealthCare
(Leverkusen, Germany) to maximize the potential of . . .
|
|